X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (39173) 39173
Publication (2413) 2413
Newsletter (447) 447
Book Review (427) 427
Book Chapter (245) 245
Magazine Article (105) 105
Newspaper Article (83) 83
Dissertation (55) 55
Conference Proceeding (45) 45
Book / eBook (21) 21
Reference (9) 9
Streaming Video (9) 9
Government Document (7) 7
Web Resource (6) 6
Paper (5) 5
Trade Publication Article (5) 5
Journal / eJournal (2) 2
Transcript (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27553) 27553
heparin (14706) 14706
female (14071) 14071
male (13382) 13382
index medicus (12871) 12871
middle aged (8982) 8982
heparin - therapeutic use (7862) 7862
aged (7555) 7555
anticoagulants - therapeutic use (7346) 7346
adult (7113) 7113
animals (6799) 6799
molecular-weight heparin (5694) 5694
anticoagulants (5596) 5596
treatment outcome (5463) 5463
hematology (5253) 5253
peripheral vascular disease (4744) 4744
thrombosis (4579) 4579
heparin - administration & dosage (4283) 4283
risk factors (4047) 4047
anticoagulants - administration & dosage (3747) 3747
surgery (3623) 3623
heparin - adverse effects (3600) 3600
anticoagulants - adverse effects (3549) 3549
cardiac & cardiovascular systems (3504) 3504
heparin, low-molecular-weight - therapeutic use (3355) 3355
thromboembolism (3191) 3191
venous thromboembolism (3141) 3141
heparin - pharmacology (3098) 3098
unfractionated heparin (3034) 3034
prevention (2924) 2924
time factors (2600) 2600
medicine, general & internal (2592) 2592
fibrinolytic agents - therapeutic use (2523) 2523
deep-vein thrombosis (2520) 2520
care and treatment (2507) 2507
pregnancy (2488) 2488
aged, 80 and over (2425) 2425
therapy (2358) 2358
retrospective studies (2301) 2301
prospective studies (2172) 2172
pharmacology & pharmacy (2166) 2166
anticoagulation (2122) 2122
glycosaminoglycans (2011) 2011
analysis (1969) 1969
research (1924) 1924
enoxaparin (1909) 1909
mice (1907) 1907
rats (1889) 1889
health aspects (1829) 1829
thrombocytopenia - chemically induced (1826) 1826
risk (1825) 1825
venous thrombosis (1788) 1788
drug therapy (1779) 1779
medicine & public health (1771) 1771
management (1727) 1727
adolescent (1723) 1723
pulmonary embolism (1704) 1704
warfarin (1703) 1703
cancer (1672) 1672
diagnosis (1586) 1586
hemorrhage - chemically induced (1563) 1563
dose-response relationship, drug (1547) 1547
heparin-induced thrombocytopenia (1540) 1540
drug therapy, combination (1536) 1536
aspirin (1499) 1499
heparin, low-molecular-weight - administration & dosage (1489) 1489
follow-up studies (1488) 1488
mortality (1457) 1457
thrombolytic therapy (1455) 1455
pulmonary-embolism (1441) 1441
biochemistry & molecular biology (1438) 1438
venous thrombosis - drug therapy (1430) 1430
prophylaxis (1422) 1422
anticoagulants - pharmacology (1380) 1380
complications (1341) 1341
abridged index medicus (1319) 1319
oncology (1307) 1307
recurrence (1293) 1293
thromboembolism - prevention & control (1285) 1285
acute disease (1236) 1236
low molecular weight heparin (1233) 1233
risk assessment (1210) 1210
platelet aggregation inhibitors - therapeutic use (1208) 1208
venous thrombosis - prevention & control (1194) 1194
thrombocytopenia (1192) 1192
proteins (1189) 1189
patients (1187) 1187
thrombosis - prevention & control (1187) 1187
aspirin - therapeutic use (1172) 1172
warfarin - therapeutic use (1168) 1168
cell biology (1164) 1164
pulmonary embolism - drug therapy (1160) 1160
thrombosis - drug therapy (1151) 1151
blood coagulation - drug effects (1150) 1150
heparin, low-molecular-weight - adverse effects (1145) 1145
myocardial infarction - drug therapy (1123) 1123
cells, cultured (1114) 1114
thrombin (1107) 1107
child (1106) 1106
coagulation (1096) 1096
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (36007) 36007
French (1157) 1157
German (1090) 1090
Russian (494) 494
Japanese (371) 371
Spanish (336) 336
Italian (203) 203
Polish (171) 171
Chinese (153) 153
Portuguese (53) 53
Hungarian (44) 44
Czech (40) 40
Danish (40) 40
Dutch (34) 34
Korean (31) 31
Swedish (30) 30
Bulgarian (29) 29
Romanian (26) 26
Turkish (22) 22
Norwegian (21) 21
Ukrainian (20) 20
Finnish (17) 17
Croatian (11) 11
Serbian (11) 11
Slovak (9) 9
Hebrew (6) 6
Lithuanian (4) 4
Slovenian (4) 4
Bosnian (1) 1
Estonian (1) 1
Icelandic (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Thrombosis and haemostasis, ISSN 0340-6245, 2015, Volume 114, Issue 6, pp. 1268 - 1276
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 7, pp. 615 - 624
In a randomized trial, 1050 patients with cancer who had acute venous thromboembolism were assigned to receive either dalteparin or edoxaban for 6 to 12... 
PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | THROMBOSIS | VITAMIN-K ANTAGONISTS | TREATMENT GUIDELINES | Anticoagulants | Hematology | Embolisms | Pulmonary arteries | Body weight | Metastasis | Thrombosis | Cancer therapies | Bleeding | Medicine | Heparin | Thromboembolism | Health risk assessment | Drug dosages | Veins & arteries | Cancer
Journal Article
Circulation, ISSN 0009-7322, 2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | CARDIAC & CARDIOVASCULAR SYSTEMS | FONDAPARINUX | THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | RIVAROXABAN | INITIAL TREATMENT | PERIPHERAL VASCULAR DISEASE | ORAL ANTICOAGULANT-THERAPY | APIXABAN | UNFRACTIONATED HEPARIN | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article
Journal Article
Chest, ISSN 0012-3692, 06/2008, Volume 133, Issue 6, pp. 340S - 380S
Journal Article
Chest, ISSN 0012-3692, 06/2008, Volume 133, Issue 6, pp. 257S - 298S
Journal Article